[Current knowledge in the treatment of chronic hepatitis C].
Pirotte
J
J
Service d'Hépato-Gastroentérologie, Université de Liège.
D000367:Age Factors; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000628:therapy* / Q000821:virology; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis; D012254:Ribavirin / Q000008:administration & dosage; D012307:Risk Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin
Acquisitions récentes dans le traitement de l'hépatite C chronique.